Kiromic BioPharma Inc.

1.50
0.00 (0.00%)
At close: Feb 28, 2025, 3:17 PM
0.00
-100.00%
After-hours: Dec 31, 1969, 07:00 PM EST

Kiromic BioPharma Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 2.8M 2.07M 469.8K 200K 87.5K 80.9K
Gross Profit n/a -2.8M -2.07M -469.8K -200K -87.5K -80.9K
Operating Income -23.77M -19.94M -31.11M -25.74M -19.2M -3.71M -3.18M
Interest Income n/a n/a n/a n/a n/a n/a n/a
Pretax Income -26.9M -20.95M -34.73M -25.59M -19.2M -3.73M -3.82M
Net Income -26.9M -21.29M -38.18M -25.65M -19.2M -3.75M -3.82M
Selling & General & Admin 8.85M 7.52M 17.19M 13.94M 14.14M 2.5M 1.76M
Research & Development 6.85M 9.62M 13.92M 11.37M 5.05M 1.2M 1.42M
Other Expenses 8.07M n/a n/a 53.4K n/a n/a n/a
Operating Expenses 23.77M 17.14M 31.11M 25.31M 19.2M 3.71M 3.18M
Interest Expense -3.72M -1.85M 166.5K 12.2K 3.3K 22.5K 633.1K
Selling & Marketing Expenses n/a -2.8M n/a n/a n/a n/a n/a
Cost & Expenses n/a 19.94M 31.11M 25.31M 19.2M 3.71M 3.18M
Income Tax n/a n/a 3.45M 65.6K 3.3K 22.5K -80.24K
Shares Outstanding (Basic) 26.07M 32.93M 16.34M 11.42M 7.28M 3.88M 3.53M
Shares Outstanding (Diluted) 26.07M 32.93M 16.34M 11.42M 7.28M 3.88M 3.53M
EPS (Basic) -1.03 -21.41 -70.12 -67.4 -79.08 -29 -32.4
EPS (Diluted) -1.03 -21.41 -70.12 -67.4 -79.08 -29 -32.4
EBITDA -23.77M -16.3M -32.5M -25.74M -19M -3.62M -3.1M
Depreciation & Amortization n/a 2.8M 2.07M 469.8K 200K 87.5K 80.9K